Therefore, the therapeutic strategy of concurrent radiotherapy and ICI instead of sequential radiotherapy and ICI was selected in vivo, and the encouraging results revealed that TREM2 inhibition prominently improved the anti-GBM effects of radiotherapy and PD-1 inhibitor (Fig. 6). This evidence concerns the gene TREM2 and glioblastoma.